4.1 Diagnostic Protocols: Adult PSG, Pediatric Testing & HSAT

4.1 Diagnostic Protocols: Adult PSG, Pediatric Testing & HSAT

In clinical sleep medicine, diagnostic testing protocols establish the physiological baseline required to diagnose sleep-disordered breathing, movement disorders, parasomnias, and disorders of hypersomnolence. On the Certified Polysomnographic Technician (CPSGT) examination, technicians must master the operational differences, technical standards, patient preparation workflows, and clinical limitations distinguishing attended in-laboratory adult polysomnography (Type I PSG), pediatric polysomnography, and Home Sleep Apnea Testing (HSAT / Type III & IV devices).

---

1. Adult Diagnostic Polysomnography (Type I PSG) Protocol

Attended, in-laboratory polysomnography represents the gold standard diagnostic modality in sleep medicine. The American Academy of Sleep Medicine (AASM) Manual for the Scoring of Sleep and Associated Events establishes strict technical criteria for baseline diagnostic recordings.

+-----------------------------------------------------------------------------+
|                 AASM ATTENDED DIAGNOSTIC PSG (TYPE I) STANDARDS             |
|                                                                             |
|   RECORDING DURATION:    Minimum 6.0 hours (360 min) of recording time (TRT)|
|                          Optimal: 7.0 to 8.0 hours based on habitual sleep  |
|                                                                             |
|   ENVIRONMENTAL CONTROLS:                                                   |
|   - Ambient Temperature: 68°F to 72°F (20°C to 22°C), individually set     |
|   - Acoustic Isolation:  < 30 to 35 dB ambient background sound level       |
|   - Lighting:            Total light extinction during sleep period         |
|   - Video / Audio:       Continuous synchronized low-light IR video & audio |
|                                                                             |
|   CORE PHYSIOLOGICAL CHANNELS (>= 7 MANDATORY PARAMETERS):                  |
|   [1] Electroencephalography (EEG):       F4-M1, C4-M1, O2-M1 (backups: F3, C3, O1)|
|   [2] Electrooculography (EOG):           E1-M2, E2-M2                      |
|   [3] Electromyography (EMG):             Chin (mental/submental) & Tibialis|
|   [4] Electrocardiography (ECG):          Single-lead modified Lead II      |
|   [5] Respiratory Airflow:                Thermal sensor (apneas) & Nasal   |
|                                           pressure transducer (hypopneas)   |
|   [6] Respiratory Effort:                 Dual RIP belts (ribcage & abdomen)|
|   [7] Oxygen Saturation (SpO2):           Pulse oximeter (<= 3s averaging)  |
|   [8] Supplementary:                      Snore sensor, Body position sensor|
+-----------------------------------------------------------------------------+

Clinical Execution & In-Study Workflow:

1. Patient Intake & Habitual Scheduling: The patient should arrive at the sleep center 1.5 to 2 hours before their habitual bedtime to allow unhurried clinical orientation, questionnaire completion, skin preparation, and electrode application.
2. Pre-Study Biocalibrations: Conducted immediately prior to "Lights Out" with the patient resting quietly in bed (eyes open, eyes closed, look left/right/up/down, blink, clench jaw, flex feet, inhale/exhale, hold breath) to verify signal integrity, polarity, and filter responses.
3. Lights Out to Lights On: Technicians continuously monitor the acquisition console, documenting body position shifts, sleep staging transitions, respiratory events, cardiac dysrhythmias, and patient room entries. Minimum recording duration must reach at least 6 hours (360 minutes) to capture sufficient NREM and REM sleep cycles across both supine and lateral postures.
4. Post-Study Biocalibrations & Discharge: Upon "Lights On," repeat the biocalibration sequence to verify that electrodes and sensors remained functional throughout the entire night before removing leads and cleaning the patient's scalp.

---

2. Pediatric Polysomnography Modifications

Pediatric patients (infants, children, and adolescents under 18 years of age) possess distinct neurodevelopmental, physiological, and anatomical characteristics that necessitate specialized monitoring protocols.

+-----------------------------------------------------------------------------+
|                   PEDIATRIC POLYSOMNOGRAPHY SPECIAL PROTOCOLS               |
|                                                                             |
|   [CAREGIVER LODGING]    Mandatory presence of parent/guardian in the room  |
|   [CARBON DIOXIDE]       MANDATORY continuous EtCO2 or TcCO2 capnography    |
|   [SENSOR SIZING]        Pediatric-sized nasal prongs & calibrated RIP belts|
|   [PULSE OXIMETRY]       Fast averaging time (<= 3 seconds) for desaturations|
|   [BEHAVIORAL PREP]      Desensitization, medical play, Surgilast lead secure|
+-----------------------------------------------------------------------------+

Critical Pediatric Technical Adaptations:

1. Continuous Carbon Dioxide Monitoring ($EtCO_2$ / $TcCO_2$):
   • AASM Mandatory Standard: Continuous non-invasive assessment of alveolar ventilation via End-Tidal $CO_2$ ($EtCO_2$) or Transcutaneous $CO_2$ ($TcCO_2$) is required for all pediatric diagnostic sleep studies.
   • Clinical Rationale: Children frequently exhibit sleep-related hypoventilation or prolonged partial upper airway obstruction without discrete apneas. Obstructive hypoventilation in pediatrics produces progressive hypercapnia ($CO_2$ retention) and hypoxemia rather than classic adult cyclic discrete obstructive events.
   • Pediatric Hypoventilation Criteria: $CO_2$ levels exceeding $50\text{ mmHg}$ for $> 25%$ of Total Sleep Time (TST), or a peak $CO_2 > 53\text{ mmHg}$ during sleep.
2. Sensor Sizing & Application:
   • Nasal cannula prongs must occupy no more than 50% of the nares to avoid creating artificial mechanical resistance or mouth breathing.
   • RIP effort belts must be appropriately sized and snug to prevent slippage on small chest walls.
3. Child-Centered Behavioral Preparation:
   • Technicians should employ age-appropriate language, demonstrate electrode placement on a stuffed animal ("medical play"), and bundle lead wires securely within tubular elastic netting (Surgilast) behind the child's clothing to prevent accidental dislodgement.

---

3. Home Sleep Apnea Testing (HSAT / OCST) Classifications

Out-of-Center Sleep Testing (OCST), commonly termed Home Sleep Apnea Testing (HSAT), utilizes portable recording devices designed for unattended diagnostic evaluation of Obstructive Sleep Apnea in the patient's home environment.

+-----------------------------------------------------------------------------+
|               AASM / CMS SLEEP TESTING DEVICE CLASSIFICATION                |
|                                                                             |
|   TYPE I:   Comprehensive attended in-lab PSG (>= 7 channels including EEG) |
|   TYPE II:  Comprehensive unattended portable PSG (>= 7 channels with EEG)  |
|   TYPE III: Modified portable sleep apnea test (MINIMUM 4 CHANNELS):        |
|             - 2 Respiratory channels (airflow + respiratory effort)         |
|             - 1 Cardiac channel (heart rate or single-lead ECG)             |
|             - 1 Pulse Oximetry channel (oxygen saturation)                  |
|   TYPE IV:  Continuous 1 to 2 channel recording (e.g., oximetry alone, or   |
|             oximetry + airflow, or Peripheral Arterial Tone [PAT] devices)  |
+-----------------------------------------------------------------------------+

Comparison of Sleep Testing Modalities:

---

4. Indications, Contraindications & Limitations of HSAT

The AASM Clinical Practice Guideline establishes strict clinical boundaries governing the appropriate utilization of HSAT.

+-----------------------------------------------------------------------------+
|                        HSAT CLINICAL DECISION MATRIX                        |
|                                                                             |
|   APPROPRIATE INDICATIONS:                                                  |
|   - High pre-test probability of uncomplicated moderate-to-severe OSA       |
|   - Documented by clinical history, loud snoring, witnessed apneas,         |
|     elevated Epworth (>10), and high STOP-BANG (>=5)                        |
|   - Follow-up of response to oral appliances or surgical therapy            |
|                                                                             |
|   ABSOLUTE & RELATIVE CONTRAINDICATIONS (MANDATE IN-LAB PSG):               |
|   - Significant comorbid pulmonary disease (COPD, severe asthma)            |
|   - Congestive Heart Failure (CHF, NYHA Class II-IV)                        |
|   - Neuromuscular disease (ALS, myasthenia gravis, spinal cord injury)      |
|   - Suspected Central Sleep Apnea or Cheyne-Stokes Breathing                |
|   - Chronic high-dose opioid use                                            |
|   - Suspected Parasomnias, Nocturnal Seizures, or REM Behavior Disorder     |
|   - Suspected Narcolepsy or Idiopathic Hypersomnia                          |
|   - Comorbid severe insomnia or circadian rhythm sleep-wake disorders      |
|   - Pediatric patients (< 18 years of age)                                  |
+-----------------------------------------------------------------------------+

Critical Diagnostic Limitations of HSAT:

1. Absence of EEG (Cannot Stage Sleep):

   • HSAT devices lack electroencephalographic leads; therefore, sleep cannot be staged (no N1, N2, N3, or REM identification).
   • Total Sleep Time (TST) cannot be measured. Instead, the device calculates metrics based on Total Monitoring Time (TMT) or Total Recording Time (TRT).

2. Respiratory Event Index (REI) vs. Apnea-Hypopnea Index (AHI):

   • In-lab PSG calculates true $\text{AHI} = \frac{\text{Apneas} + \text{Hypopneas}}{\text{Total Sleep Time (hours)}}$.
   • HSAT calculates the Respiratory Event Index (REI): $\text{REI} = \frac{\text{Total Apneas} + \text{Total Hypopneas}}{\text{Total Monitoring Time (hours)}}$
   • The Dilution Effect: If a patient with severe insomnia sleeps only 3 hours during an 8-hour HSAT monitoring period, all respiratory events are divided by 8 hours instead of 3 hours. This artificially dilutes the event index, potentially turning severe OSA into a false-negative normal study.

3. Hypopnea Scoring Limitations:

   • On Type I PSG, hypopneas can be scored if associated with either $\ge 3%$ oxygen desaturation OR an electroencephalographic cortical arousal.
   • On standard Type III HSAT, cortical arousals cannot be detected; therefore, only desaturation-based hypopneas ($\ge 3%$ or $\ge 4%$) can be scored, leading to systematic underestimation of milder respiratory events.

4. Mandatory In-Lab Follow-Up:

   • If an HSAT returns negative, inconclusive, or technically inadequate in a patient with persistent clinical symptoms of sleep apnea, an attended in-laboratory polysomnography (Type I) is medically mandatory to establish a definitive diagnosis.